Key result
Continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea significantly improved C-reactive protein levels (pooled mean difference 0.14; 95% CI 0.08 to 0.20; p<0.00001).
Why the study?
Does CPAP treatment reduce levels of inflammatory markers (CRP, TNF-α, IL-6) in adult patients with obstructive sleep apnea?
Meta-Analysis
Does CPAP treatment reduce levels of inflammatory markers (CRP, TNF-α, IL-6) in adult patients with obstructive sleep apnea?
Effect estimate: Pooled mean difference 0.14 (95% CI 0.08 to 0.20)
p-value: p=< 0.00001
CPAP therapy in patients with obstructive sleep apnea significantly reduces systemic inflammatory markers (CRP and TNF-α), which may help modulate their cardiovascular risk profile.
No takes yet. Share an insight, caveat, or question.
Supports CPAP to lower CRP in OSA; extends evidence for CV risk modulation but requires outcome trials.
Baessler et al. (2013) conducted a meta-analysis in Obstructive sleep apnea (OSA). Continuous positive airway pressure (CPAP) vs. Baseline (before CPAP treatment) was evaluated on C-reactive protein (CRP) levels (Pooled mean difference 0.14, 95% CI 0.08 to 0.20, p=< 0.00001). Continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea significantly improved C-reactive protein levels (pooled mean difference 0.14; 95% CI 0.08 to 0.20; p<0.00001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: